Versant Venture Capital V, L.P. Insider Trading $GRTS Gritstone bio, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Versant Venture Capital V, L.P..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Versant Venture Capital V, L.P.. Versant Venture Capital V, L.P. is 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and 10% Owner in CRISPR Therapeutics AG ($CRSP) and 10% Owner in Gritstone Oncology, Inc. ($GRTS).

Versant Venture Capital V, L.P. in Gritstone bio, Inc.

Trading Symbol: GRTS
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Versant Venture Capital V, L.P.: 10% Owner
Holdings: 3,102,929 shares
Latest Transaction: Oct 02 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Versant Venture Capital V, L.P. in Gritstone bio, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CRNX, CRSP, GRTS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 02 2018GRTSGritstone Oncology ...Versant Venture Capital V, L.P ...10% OwnerOption ExerciseC0.00929,02000
Oct 02 2018GRTSGritstone Oncology ...Versant Venture Capital V, L.P ...10% OwnerOption ExerciseC0.002,173,90900
Oct 02 2018GRTSGritstone Oncology ...Versant Venture Capital V, L.P ...10% OwnerBuyC0.003,102,92903,102,9290 to 3.1 M

Page:   1